As a global leader in generic medicines with a strong innovative portfolio, we are all in for better health.

Today, Teva portfolio of around 3,600 products is among the largest of any pharmaceutical company in the world. Nearly 200 million people in 60 countries benefit from one of Teva’s quality medicines every day. We invest in research and development of innovative medicines, generic drugs and biosimilars, carrying on the legacy of more than a century of finding new ways to help patients improve their lives. This defines our values as a company and characterizes how we do business and approach medicine.

In Bulgaria Teva / until 2020 known as Actavis / is the largest pharmaceutical company in terms of production capacity and number of employees, with the richest product portfolio with clearly defined focus therapeutical areas.

Teva’s two pharmaceutical plants in the towns of Dupnitsa and Troyan have a nearly 70-year history in the Bulgarian pharmaceutical production.